Clinical Trials
3
Active:1
Completed:0
Trial Phases
1 Phases
Phase 3:2
Drug Approvals
2
EMA:2
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (100.0%)No trials found
News
Henlius' Serplulimab Makes History as First PD-1 Inhibitor Approved in EU for Small Cell Lung Cancer
Shanghai Henlius Biotech's serplulimab (Hetronifly) receives European Commission approval as the first anti-PD-1 antibody for extensive-stage small cell lung cancer treatment.